These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26238228)

  • 1. Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia.
    Sacuiu S; Insel PS; Mueller S; Tosun D; Mattsson N; Jack CR; DeCarli C; Petersen R; Aisen PS; Weiner MW; Mackin RS;
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):126-35. PubMed ID: 26238228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
    Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM;
    Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.
    Moon B; Kim S; Park YH; Lim JS; Youn YC; Kim S; Jang JW;
    J Alzheimers Dis; 2017; 58(4):1255-1264. PubMed ID: 28550264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 9.  Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression.
    Gonzales MM; Insel PS; Nelson C; Tosun D; Mattsson N; Mueller SG; Sacuiu S; Bickford D; Weiner MW; Mackin RS;
    Am J Geriatr Psychiatry; 2017 Sep; 25(9):980-991. PubMed ID: 28629965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.
    Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Takeuchi H; Gerretsen P; Iwata Y; Patel R; Mulsant BH; Graff-Guerrero A
    J Alzheimers Dis; 2016; 49(3):743-54. PubMed ID: 26519442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
    Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Defrancesco M; Marksteiner J; Kemmler G; Fleischhacker WW; Blasko I; Deisenhammer EA
    J Alzheimers Dis; 2017; 59(4):1439-1448. PubMed ID: 28731429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD.
    Spulber G; Niskanen E; Macdonald S; Kivipelto M; Padilla DF; Julkunen V; Hallikainen M; Vanninen R; Wahlund LO; Soininen H
    Curr Alzheimer Res; 2012 May; 9(4):516-24. PubMed ID: 22191564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
    Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
    Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.
    Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Gerretsen P; Iwata Y; Graff-Guerrero A;
    J Geriatr Psychiatry Neurol; 2016 May; 29(3):149-59. PubMed ID: 26400248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.